Browsing by Author Sullivan, Ryan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2016Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersCarlino, Matteo; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Buchbinder, Elizabeth I; et al, Various; Johnson, Douglas B; Khushalani, Nikhil I; Lawrence, Donald; Mudigonda, Tejaswi; Ott, Patrick A; Puzanov, Igor; Sullivan, Ryan; Ye, Fei; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineIpilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders, JAMA Oncology, vol.2, 2, 2016,pp 234-240
2014Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitorsKefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Ackerman, Allison; Atkins, Michael; Flaherty, Keith; Gunturi, Anasuya; Hodi, F. Stephen; Ibrahim, Nageatte; Klein, Oliver; Lawrence, Donald; McDermott, David; Sullivan, Ryan; Wang, Wei; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineOutcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors, Cancer, vol.120, 11, 2014,pp 1695-1701
2017Phase I dose-escalation and -expansion study of the BRAF inhibitor encorafenib (LGX818) in metastatic BRAF-mutant melanomaCarlino, Matteo; Kefford, Richard (Rick); Arance, Ana; Delord, Jean-Pierre; et al, Various; Kudchakar, Ragini; Mahipal, Amit; McArthur, Grant A.; Nyakas, Marta; Robert, Caroline; Sullivan, Ryan; Yamada, Yasuhide; Westmead Clinical School: Medicine; Westmead Clinical School: MedicinePhase I dose-escalation and -expansion study of the BRAF inhibitor encorafenib (LGX818) in metastatic BRAF-mutant melanoma, Clinical Cancer Research, vol.23, 18, 2017,pp 5339-5348